Journal
CURRENT OPINION IN CHEMICAL ENGINEERING
Volume 3, Issue -, Pages 83-90Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coche.2013.12.001
Keywords
-
Funding
- NIH Common Fund for the Microphysiological Systems Initiative
- [UH2TR000505]
Ask authors/readers for more resources
Considerable advances have occurred in the development of tissue-engineered blood vessels (TEBVs) to repair or replace injured blood vessels, or as in vitro systems for drug toxicity testing. Here we summarize approaches to produce TEBVs and review current efforts to (1) identify suitable cell sources for the endothelium and vascular smooth muscle cells, (2) design the scaffold to mimic the arterial mechanical properties and (3) regulate the functional state of the cells of the vessel wall. Initial clinical studies have established the feasibility of this approach and challenges that make TEBVs a viable alternative for vessel replacement are identified.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available